Benefits of polyunsaturated fatty acid (PUFA) supplementation in therapy of children and teenagers with Asperger?s Syndrome

Completed

• Conditions: Asperger's syndrome; Mental and Behavioural Disorders

• Registration Number: ISRCTN20233876
• Lead Sponsor: Indywidualna Specjalistyczna Praktyka Lekarska w Miejscu Wezwania (Poland)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2012-09-27
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

1. Diagnosis of Asperger?s syndrome according to ICD-10 (normal IQ)
2. Age 6 ? 19 years

Exclusion Criteria

Patients meeting at least one of below mentioned criteria (in the past or currently) will be excluded from participation in the study:
1. Bipolar disease
2. Psychotic disorders
3. Immunological disorders
4. Administration of PUFA or other fat supplements (e.g. lecithin) during last 3 months
5. Body mass index (BMI) lower than 18
6. Convulsions in the history (excluding high temperature convulsions)
7. Administration of epileptic drugs currently or in the past
8. Administration of alcohol or narcotic drugs during the last 3 months
9. Blood hypertension
10. Hyper- or hypothyroidism
11. Diabetes or glucose intolerance
12. Hyperlipidemia
13. Clotting abnormalities
14. Other acute or chronic diseases currently or in the past

Study & Design

• Study Type: Interventional
• Study Design: Not specified